Benralizumab pregnancy exposure study

Trial Identifier:	D3250R00026
Sponsor:	AstraZeneca
Collaborator:	University of California, San Diego, Department of Pediatrics
NCTID::	NCT03794999
Start Date:	March 2019
Primary Completion Date:	December 2023
Study Completion Date:	December 2023
Condition:	Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
United States of America, CA	San Diego, CA, United States of America, 92103

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.